Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Selection Criteria

    Grants are available to physicians, scientists and hematology laboratory staff working in a hospital or research organisation. Building local capacity and resource sustainability are important criteria for this iCMLf funding.

    To ensure a wide range of participants in the program only one grant per institution/department will be awarded.

    The grants will be awarded based on evaluation of submitted proposals by the iCMLf Directors. The proposals should clearly demonstrate how the funded activity would improve access to diagnosis and testing along with the following criteria:

    • How the project will impact an existing area of need
    • How iCMLf funding will underpin the development of on site facilities
    • How the project utilises both the partnership with the CML centre of excellence and the iCMLf funding
    • What consideration has been given to the sustainability of access to diagnostics
    • A clear plan of action with a plan to report measurable outcomes

    Grants are available to physicians, scientists and hematology labotatory staff working in a hospital, or research institurion. Building local capacity and resource sustainability are important criteria for thei iCMLf funding. 

    To ensure a wide range of participants in the program only one grant per institution/department will be awarded.